J.P. Gabriel

Chief Tech/Sci/R&D Officer at SILENCE THERAPEUTICS PLC

Health Technology

Commercial Services

Consumer Services

Profile

John Paul Gabriel is currently Chief Technical Operations Officer at Silence Therapeutics Plc since 2022.
Formerly, Mr. Gabriel was Senior Vice President-Technical Operations at Ocugen, Inc. from 2021 to 2022 and Vice President-Biologics & mRNA Manufacturing at Ultragenyx Pharmaceutical, Inc. Education includes an undergraduate degree from the University of Guelph.

J.P. Gabriel active positions

Companies	Position	Start
SILENCE THERAPEUTICS PLC	Chief Tech/Sci/R&D Officer	31/10/2022

All active positions of J.P. Gabriel

Former positions of J.P. Gabriel

Companies	Position	End
OCUGEN, INC.	Corporate Officer/Principal	31/08/2022
ULTRAGENYX PHARMACEUTICAL INC.	Corporate Officer/Principal	-

See the detail of J.P. Gabriel's experience

Training of J.P. Gabriel

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of J.P. Gabriel's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Ultragenyx Pharmaceutical, Inc. Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases	Health Technology
Silence Therapeutics Plc Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products	Commercial Services
University of Guelph University of Guelph Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Ocugen, Inc. Ocugen, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes gene therapy products	Health Technology